Patent · US Expired

Angiogenesis related molecules

US6908898B1 · kind B1 · utility

0Cited by
2References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 14, 1999
Grant dateJun 21, 2005
Priority date
Expiry dateJun 14, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides the sequence of a protein capable of acting as an angiostatin receptor as well as the nucleic acid sequence thereof. The invention also relates to the use thereof in screening methods, wherein novel substances are created exhibiting the same advantageous anti-angiogenic properties as angiostatin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.